Ovid Therapeutics Inc.

OVID · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.5B · 23 employees
203
SEC Filings
$2.8
Close 2026-08-28
23
Employees

Business Summary

Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing small molecule medicines for brain disorders, including epilepsies and psychoses. Its pipeline includes OV329, a GABA-aminotransferase inhibitor for drug-resistant focal onset seizures, TSC, and infantile spasms; OV4071, an oral KCC2 direct activator for psychosis associated with Parkinson's disease and Lewy body dementia; and OV350, an IV KCC2 direct activator. The company targets neuronal hyperexcitability through first-in-class or best-in-class mechanisms of action.

Latest Stock Quote

OVID 2026-08-28 $2.8 O:$2.87 H:$2.93 L:$2.76 Vol:1.7M VWAP:$2.828
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001628280-26-019438EDGAR69K words
2025-03-112024-12-310001628280-25-011844EDGAR67K words
2024-03-082023-12-310001628280-24-009809EDGAR65K words
2023-03-132022-12-310001628280-23-007648EDGAR66K words
2022-03-152021-12-310000950170-22-003668EDGAR—
2021-03-152020-12-310001564590-21-013016EDGAR—
2020-03-112019-12-310001564590-20-010108EDGAR—
2019-03-072018-12-310001564590-19-006804EDGAR—
2018-03-292017-12-310001564590-18-007152EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001628280-26-056498EDGAR50K words
2025-11-122025-09-300001636651-25-000012EDGAR51K words
2025-08-132025-06-300001628280-25-040008EDGAR50K words
2025-05-132025-03-310001628280-25-024913EDGAR48K words
2024-11-122024-09-300001628280-24-046868EDGAR50K words
2024-08-132024-06-300001628280-24-036860EDGAR48K words
2024-05-142024-03-310001628280-24-023067EDGAR45K words
2023-11-032023-09-300001628280-23-036564EDGAR49K words
2023-08-042023-06-300001628280-23-027430EDGAR48K words
2023-05-052023-03-310001628280-23-016013EDGAR46K words
2022-11-082022-09-300001628280-22-028772EDGAR—
2022-08-092022-06-300001628280-22-021759EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-130001628280-26-056497EDGAR2K words
2026-03-180001628280-26-019045EDGAR20K words
2025-12-180001193125-25-323798EDGAR1K words
2025-12-110001636651-25-000017EDGAR1K words
2025-11-120001636651-25-000011EDGAR3K words
2025-10-030001193125-25-230409EDGAR3K words
2025-09-160001193125-25-204308EDGAR0K words
2025-08-130001628280-25-040007EDGAR3K words
2025-07-100001628280-25-034733EDGAR1K words
2025-06-250001628280-25-032959EDGAR1K words

203 total filings indexed. 172 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

epilepsy-and-seizure-disorders developmental-and-epileptic-encephalopathies-(dees) tuberous-sclerosis-complex-(tsc) infantile-spasms psychosis-associated-with-parkinson's-disease lewy-body-dementia schizophrenia mood-disorders central-nervous-system-(cns)-therapeutics

Company Identity

CIK0001636651
TickerOVID
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.ovidrx.com
Listed2017-05-05

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 8ee7f6656e4162afd75e247106b3cd4dd5e4c0e393dfb8e0ef04cef22bbc2fe0
parent: fc6ed5257899ac05fa69f6ca99cad3ff647e6d28801f34768bdf37777947326d
content hash: e8f6759d80cf901927764dd47ad15c5212d61cbbb2b1fdab4a521dfea0506572
signed: 2026-09-29T12:02:36.631Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up OVID using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on OVID, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/OVID (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.